反応 #44437

ord-65d4b72cde144581bdaebd6c8dfe058f

反応方程式

CCOC(C)=O
ethyl acetate
O=C([O-])O.[Na+]
sodium bicarbonate
N[C@@H]1CCCN2c3cc(Cl)ccc3Oc3ccccc3[C@H]12
trans-7-chloro-2,3,4,14b-tetrahydro-1H-dibenzo[b,f]pyrido[1,2-d][1,4]oxazepine-1-amine
O=C(Cl)OCCl
chloromethyl chloroformate
O=C(N[C@@H]1CCCN2c3cc(Cl)ccc3Oc3ccccc3[C@H]12)OCCl
trans-(7-chloro-2,3,4,14b-tetrahydro-1H-dibenzo[b,f]pyrido[1,2-d][1,4]oxazepin-1-yl)carbamic acid chloromethyl ester
収率 88.0%

溶媒

反応条件

詳細条件
See reaction.notes.procedure_details.

後処理

  1. 1
    洗浄the organic layer was washed with water
  2. 2
    乾燥dried (Na2SO4)
  3. 3
    その他evaporated

実験手順

100 μL of saturated aq. sodium bicarbonate was added to trans-7-chloro-2,3,4,14b-tetrahydro-1H-dibenzo[b,f]pyrido[1,2-d][1,4]oxazepine-1-amine (9.5 mg, 0.03 mmol) and chloromethyl chloroformate (64.2 μL, 0.42 mmol) in 250 μL of CH2Cl2. The resulting mixture was stirred at room temperature for 18 h. Subsequently, ethyl acetate was added and the organic layer was washed with water, dried (Na2SO4) and evaporated to give trans-(7-chloro-2,3,4,14b-tetrahydro-1H-dibenzo[b,f]pyrido[1,2-d][1,4]oxazepin-1-yl)carbamic acid chloromethyl ester (9.9 mg, 88%). Data: (m/z)=393 (M+H)+.

出典

DOI: 10.6084/m9.figshare.5104873.v1特許: US07737136B2uspto-grants-2010_06